title: Valued lives: Britain stirs outcry by weighing benefits of drugs versus price; government arm finds pills for Alzheimer's too costly, angering patients, Pfizer.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Whalen
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D015276:Health Care Rationing / Q000191:economics; D006291:Health Policy / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement; D018803:Models, Economic; D010344:Patient Advocacy; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom